This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our Privacy Policy.
Collaborating for Next Generation Cell Therapies

Acepodia is actively seeking partners who are interested in collaborating to develop the next generation of cellular immunotherapies for cancer and other diseases with unmet medical needs.  We believe our ACC and CAR technologies can significantly advance the field of cellular therapeutics by directing allogeneic effector cells directly to tumors, and that our super potent proprietary cell lines can be utilized by other drug development platforms for scalable integration of tumor-targeting approaches.

Join us if you share our vision

Acepodia is committed to delivering effective and affordable treatments for patients – with an initial focus on cancer.
To discuss partnering with Acepodia, please contact: info@acepodiabio.compartnership